Bhatia Sangeeta N.'s Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Aug 10, 2022
- Accession no.
- 0000899243-22-028250
- Filed
- Aug 10, 2022
- Trade date
- Aug 8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $182.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhatia Sangeeta N.CIK 0001643921 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | SSaleDisposed | −45 | $290.18F2,F3 | −$13,058.1 | 5,237 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −164 | $291.76F2,F4 | −$47,848.64 | 5,073 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −204 | $293.15F2,F5 | −$59,802.6 | 4,869 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −161 | $294.24F2,F6 | −$47,372.64 | 4,708 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −47 | $295.53 | −$13,889.91 | 4,661 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49).
Referenced by the price of 1 transaction in Table I.